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Abstract 22 
Aberrant placental angiogenesis is associated with fetal growth restriction (FGR).  In the 23 
mouse, targeted disruption of the homeobox gene, transforming growth β-induced factor 24 
(Tgif-1), which is also a transcription factor, causes defective placental vascularisation. 25 
Nevertheless, TGIF-1’s role in human placental angiogenesis is unclear. We have previously 26 
reported increased TGIF-1 expression in human FGR placentae and demonstrated localisation 27 
of TGIF-1 protein in placental endothelial cells (ECs). However, its functional role remains 28 
to be investigated. In this study, we aimed to specifically compare TGIF-1 mRNA expression 29 
in placental ECs isolated from human FGR-affected pregnancies with gestation-matched 30 
control pregnancies in two independent cohorts from Australia and Canada, and to identify 31 
the functional role of TGIF-1 in placental angiogenesis using the human umbilical vein 32 
endothelial cell-derived cell line, SGHEC-7 and primary human umbilical vein ECs.  Real-33 
time PCR revealed that TGIF-1 mRNA expression was significantly increased in ECs 34 
isolated from FGR-affected placentae compared with that of controls. The functional roles of 35 
TGIF-1 were determined in ECs following TGIF-1 siRNA transfection.  TGIF-1 inactivation 36 
in ECs significantly reduced TGIF-1 at both the mRNA and protein levels, as well as the 37 
proliferative and invasive potential, but significantly increased the angiogenic potential. 38 
Using angiogenesis PCR screening arrays, we identified ITGAV, NRP-1, ANPGT-1 and 39 
ANPGT-2 as novel downstream targets of TGIF-1, following TGIF-1 inactivation in ECs. 40 
Collectively, these results show that increased TGIF-1 in FGR may regulate EC function 41 
through mediating the expression of angiogenic molecules and contribute to aberrant 42 
placental angiogenesis in FGR pregnancies. 43 
44 
Page 2 of 32
3 
 
Introduction 45 
Placental angiogenesis is critical for maintaining the highly efficient transport system that 46 
facilitate the exchange of nutrients, oxygen and waste between the mother and the fetus 47 
(Reynolds and Redmer 2001).  Endothelial cells (ECs) play significant roles in coordinating 48 
effective angiogenesis and aberrant EC function can lead to pregnancy pathologies such as 49 
fetal growth restriction (Bouis, et al. 2001, Kingdom, et al. 2000). Impaired placental 50 
angiogenesis is observed in FGR, with reduced tubule length and formation in placental ECs 51 
obtained from FGR-affected pregnancies (Su, et al. 2015). Placental angiogenesis is tightly 52 
controlled by numerous growth factors, cytokines and signalling pathways that collectively 53 
regulate expression of multiple genes through the activation of transcription factors (Hamik, 54 
et al. 2006, Latchman 1997). 55 
 56 
Transcription factors that regulate angiogenesis include the family of homeobox genes 57 
(Gorski and Walsh 2000).  Homeobox genes belong to a highly conserved family of 58 
transcription factors (Holland, et al. 2007), which control cell and organ differentiation 59 
throughout embryonic development (Yaron, et al. 2001) and have pleiotropic effects on cell 60 
proliferation, growth arrest and differentiation (Douville and Wigle 2007, Gorski and Walsh 61 
2000). Mouse knock-out studies demonstrate the involvement of homeobox genes in 62 
regulating placental functions (Rossant and Cross 2001).  Previous studies in our laboratory 63 
have identified that several homeobox genes including DLX3, HOXB6, DLX4, MSX2, GAX 64 
and HLX1, are expressed in ECs surrounding the fetal capillaries in the human placenta 65 
(Murthi, et al. 2007). We have also demonstrated the expression of several novel homeobox 66 
genes in placental ECs including the novel transforming growth β-induced factor (TGIF-1) 67 
homeobox gene at the mRNA level (Murthi, et al. 2008). 68 
 69 
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TGIF-1 is a negative regulator of the transforming growth factor beta (TGF-β) pathway 70 
(Faresse, et al. 2008), which is important for physiological processes such as cell 71 
proliferation, differentiation, apoptosis, early development and placental angiogenesis. 72 
Missense mutations in the TGIF-1 gene can lead to holoprosencephaly, which affects cranial 73 
development (Hayhurst and McConnell 2003). In addition, mouse studies show that Tgif-1 74 
null embryos display a severely growth restricted phenotype associated with placental 75 
vascular defects (Bartholin, et al. 2008). Our recent study showed significantly increased 76 
TGIF-1 expression in FGR placental homogenates at both the mRNA and protein levels, with 77 
protein localisation of TGIF-1 in the endothelium lining the fetal capillaries (Pathirage, et al. 78 
2013). However, the role of TGIF-1 in human placental ECs is largely unknown. 79 
 80 
In this study, we hypothesised that TGIF-1 is an important regulator of placental 81 
angiogenesis. A previous microarray analysis on placental endothelial cells (PLEC) from 82 
FGR pregnancies performed in Toronto, Canada, demonstrated a trend for increased TGIF-1 83 
mRNA expression in the FGR PLEC samples as compared with that of the controls (Dunk, et 84 
al. 2012). In the current study using the two independent cohorts from Toronto, Canada and 85 
from samples collected in Melbourne, Australia, ECs isolated from FGR placentae and 86 
control placentae were further investigated and validated for TGIF-1 expression. We aimed to 87 
determine the level of TGIF-1 mRNA expression in placental ECs isolated from FGR and 88 
gestation-matched control (GMC) pregnancies in two independent cohorts, and to investigate 89 
the functional role of TGIF-1 by gene inactivation in primary human umbilical vein 90 
endothelial cells (HUVECs) and the HUVEC-derived cell line, SGHEC-7 (Fickling, et al. 91 
1992). 92 
93 
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Materials and Methods 94 
Placental endothelial cell (PLEC) isolation 95 
PLECs were isolated and purified from two independent cohorts of placentae from 96 
Melbourne, Australia and Toronto, Canada as described previously (Dunk, et al. 2012). 97 
Placentae were collected from n=10 FGR and n=10 GMC patients in the Australian study 98 
arm and n=6 FGR and n=4 GMC patients in the Canadian study arm with written informed 99 
consent. Patient characteristics of the Australian samples are presented in Table 1. Using 100 
these placental samples, previous studies in our laboratory have shown consistent gene 101 
expression changes in the placental villi of FGR compared with gestation-matched control 102 
pregnancies (Murthi et al., 2006, Pathirage et al., 2013). FGR was defined as birthweight less 103 
than the 10th centile for gestational age according to Australian growth charts (Murthi et al., 104 
2006) accompanied by two or more of the following features: abnormal umbilical artery 105 
Doppler flow velocimetry; oligohydramnios as determined by amniotic fluid index (AFI) of 106 
<7; asymmetric growth of the fetus as defined by a head circumference (HC) to abdominal 107 
circumference (AC) ratio >1.2. The exclusion criteria for both FGR and GMC pregnancies 108 
were multiple pregnancies, illicit drug dependency, maternal smoking, pre-eclampsia, 109 
prolonged rupture of the membranes, placental abruption, intrauterine viral infection, and 110 
fetal congenital anomalies. The Australian samples were collected with approval from The 111 
Royal Women’s Hospital Human Research Ethics Committee (Project # 27/00) in 112 
Melbourne, Australia. All Canadian samples were collected by the Research Centre for 113 
Women’s and Infants’ Health BioBank Program (http://biobank.lunenfeld.ca/) with the 114 
approval of the Research Ethics Board at Mount Sinai Hospital (04-0018-U) in Toronto, 115 
Canada and the FGR and matched control samples were previously characterised by Dunk et 116 
al. (Dunk, et al. 2012). All FGR cases in the Canadian cohort were presented with abnormal 117 
umbilical Doppler velocimetry. Freshly isolated cells were used for gene expression analyses.  118 
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HUVEC isolation 119 
Human umbilical vein endothelial cells (HUVECs) were freshly isolated from uncomplicated 120 
term pregnancies (n=12) as previously described (Murthi et al. 2008). Briefly, cells were 121 
cultured and maintained in M199 tissue culture medium (Thermo Fisher Scientific, Waltham, 122 
MA, USA) with 10% fetal bovine serum supplemented with 2 mM L-glutamine, 100 U/mL 123 
penicillin, 100µg/mL streptomycin and maintained in 5%CO2/95% air. For gene expression 124 
and functional analyses HUVEC cells from passage 2 were used.  125 
 126 
SYBR Green qPCR analysis on Canadian cohort 127 
SYBR green q-PCR was performed as previously described (Dunk, et al. 2012). Breifly, 1µg 128 
of total RNA from isolated PLECs was reverse transcribed using the I Script cDNA synthesis 129 
kit (Bio-Rad Laboratories, Hercules, CA, USA). Approximately 10 ng of each cDNA was 130 
then subjected to Real-Time PCR using primers specific for TGIF (Forward 5’-131 
TCGGTGTGGGACAAAACACA-3’ and Reverse 5’-TCGGTGTGGGACAAAACACA-3’) 132 
and housekeeping genes SDHA and YWHAZ (Dunk, et al. 2012). Real-time PCR was 133 
performed in a white 96-well plate in a CFX96 real-time PCR system (Bio-Rad 134 
Laboratories). The run protocol was as follows: heat activation of Taq and denaturation 95°C 135 
for 2min, and 40 cycles of amplification at 95°C for 10s and 60°C for 30s. The mRNA level 136 
of the gene of interest from each sample was normalised to the geometric mean of the 137 
YWHAZ and SDHA mRNA expression level and data were analysed using the 2
-∆∆CT
 method 138 
(Livak and Schmittgen 2001). 139 
 140 
RNA extraction, cDNA synthesis, real-time PCR of Australian cohort and cell lysates 141 
Total cellular RNA was extracted from the Australian cohort of PLECs and EC lysates using 142 
the PureLink RNA Mini kit (Thermo Fisher Scientific Corp, Waltham, MA, USA) following 143 
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the manufacturer’s instructions. RNA yield, purity and integrity were determined by 144 
visualising 28S and 18S ribosomal RNA following 1% (w/v) agarose gel electrophoresis. 145 
First-strand cDNA was prepared as previously described (Rajaraman, et al. 2010).  Real-time 146 
PCR was performed using FAM labelled Taqman
®
 probes (ANGPT-1 Hs00375823_m1; 147 
ANGPT-2 Hs00169867_m1; ITGAV Hs00233808_m1; NRP-1 Hs00826129_m1 and TGIF-1 148 
Hs00545233_m1) and Eukaryotic 18S rRNA Endogenous Control (VIC/MGB Probe, Primer 149 
Limited) as a housekeeping gene in an ABI PRISM 7500HT thermocycler (Applied 150 
Biosystems, Carlsbad, CA, USA).  Approximately 12.5 ng/µL of cDNA was amplified in a 151 
total reaction volume of 20 µL.  PCR conditions included an activation cycle of 50°C for 2 152 
minutes and 95°C for 10 minutes followed by 40 cycles of 95°C for 15 seconds and 60°C for 153 
1 minute. Relative mRNA expression for each gene to the 18S rRNA housekeeping gene was 154 
determined using the 2
-∆∆CT
 method (Livak and Schmittgen 2001). 155 
 156 
Cell culture 157 
The well characterised HUVEC-derived cell line, SGHEC-7, was cultured as previously 158 
described (Fickling, et al. 1992).  Briefly, cells were grown in a 1:1 mixture of RPMI 1640 159 
and medium 199 supplemented with 10% (v/v) heat-inactivated fetal bovine serum, 1% (w/v) 160 
L-glutamine, 100 IU/mL penicillin and 100 mg/mL streptomycin.  Cells were maintained in 161 
controlled, humidified conditions at 37°C in 5% CO2 and 95% air. 162 
 163 
Immunocytochemistry 164 
Immunocytochemistry was performed using the Zymed
®
 Histostain-plus Broad Spectrum kit 165 
(Thermo Fisher Scientific Corp) as previously described (Lepparanta, et al. 2010).  Mouse 166 
anti-TGIF-1 monoclonal IgG (0.02 µg/µL; Santa Cruz Biotechnology Inc., Santa Cruz, CA, 167 
USA) in 2% (w/v) non-fat milk in phosphate buffered saline was used to detect TGIF-1 168 
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protein.  Mouse IgG2b (Dako, Glostrup, Denmark) was used as a negative control.  Colour 169 
detection was performed using the Zymed
®
 AEC chromogen kit (Thermo Fisher Scientific 170 
Corp) and slides were mounted with 80% (v/v) glycerol.  Cells were viewed with a Zeiss 171 
Axioscope microscope and images were captured with a Zeiss Axiocam camera and analysed 172 
using Axiovision Rel. 4.3 software (Carl Zeiss AG, Oberkochen, Germany). 173 
 174 
TGIF-1 inactivation in ECs 175 
Two independently validated siRNAs, TGIF-1 siRNA-1 (S1) and TGIF-1 siRNA-2 (S2) from 176 
Life Technologies Corp. (Carlsbad, CA, USA), were used to silence TGIF-1 expression in 177 
ECs.  TGIF-1 oligonucleotides was diluted to 80 µM with RNAifect transfection reagent 178 
(Qiagen, Hilden, Germany) added drop-wise to cells grown in 6 well plates and incubated for 179 
72 hours in culture.  AllStars Negative Control siRNA (Qiagen) that had no homology to any 180 
known mammalian gene was used as a negative control (NC). 181 
 182 
Protein extraction and western immunoblotting 183 
Whole cell protein was extracted using radio immunoassay precipitation assay buffer 184 
containing 50mM TrisHCl, 150mM NaCl, 1% (v/v) Trition-X-100, 1% (w/v) sodium 185 
deoxycholate and 0.1% (w/v) sodium dodecyl sulphate supplemented with 1X protease and 186 
1X phosphatase inhibitor cocktails (Roche, Basel, Switzerland). Immunoblotting was then 187 
performed as previously described (Murthi, et al. 2006).  Mouse anti- TGIF-1 monoclonal 188 
IgG (0.02 µg/µL; Santa Cruz Biotechnology Inc.) and rabbit anti-GAPDH polyclonal IgG 189 
(1.25 ng/µL; Imgenex Corp., San Diego, CA, USA) were used to detect TGIF-1 and GAPDH 190 
protein respectively.  Horseradish peroxidase (HRP)-conjugated goat anti-mouse IgG (1 191 
ng/µL; Thermo Fisher Scientific Corp) or HRP-conjugated goat anti-rabbit IgG (1.5 ng/µL, 192 
Thermo Fisher Scientific Corp) were used as secondary antibodies. Immunoreactivity was 193 
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detected using an enhanced chemiliuminescence system (GE Healthcare, Little Chalfont, UK) 194 
and the luminescence detector LAS-4000 image reader (Fujifilm Corp., Tokyo, Japan). 195 
Immunoreactive protein bands were quantitated using the ImageJ software. Levels of TGIF-1 196 
was normalised to that of GAPDH to control for protein loading.  197 
 198 
Cell proliferation assay 199 
Cell proliferation was assessed using the CellTiter 96
®
 Aqueous One Cell Proliferation Assay 200 
(Promega Corp., Madison, WI, USA) following the manufacturer’s instructions. Briefly, 201 
2x10
4
 SGHEC-7 cells were transfected with either TGIF-1 siRNA-1 or siRNA-2 and plated 202 
in a 96-well plate in serum-free medium. After 24 hours of culture (72 hours post-203 
transfection) the cell proliferation assay was performed and the plate read at λ490. 204 
 205 
Zymography 206 
The effect of TGIF-1 siRNA inactivation on the activity of metalloproteinases was assessed 207 
using gelatin-based zymography as described previously (Fitzsimmons, et al. 2007). 208 
Dehydrated gels were scanned on an ImageScanner III densitometer (GE Healthcare) and 209 
band intensities were quantified using the ImageQuant software provided with the instrument. 210 
 211 
Network formation assay 212 
To observe the effect of TGIF-1 inactivation on the network formation ability of ECs, 24-213 
well plates were coated with a thin layer of undiluted growth factor reduced Matrigel™ (BD 214 
Biosciences, San Jose, CA, USA).  At 48 hours post transfection, 2x10
5
 cells were seeded 215 
onto the pre-coated plates and incubated in complete basal medium for a further 24 hours as 216 
previously described (Arnaoutova and Kleinman 2010).  Images were taken every 4 hours 217 
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throughout the 24 hours using the Incucyte™ live cell imaging system (Essen Bioscience, 218 
Ann Arbor, MI, USA) at a magnification of 200X. 219 
 220 
Angiogenesis array 221 
The effect of TGIF-1 silencing on angiogenic genes was determined using TaqMan
®
 human 222 
angiogenesis signature arrays (Applied Biosystems), which consisted of 92 human genes 223 
involved in the regulation of angiogenesis.  Gene profiling was used to identify the 224 
downstream target genes of TGIF-1 and the methodology was carried out according to the 225 
manufacturer’s instructions.  Briefly, cDNA was prepared using an RT
2
 First Strand kit and 226 
added to a TaqMan
®
 Universal mastermix which contained the AmpliTaq Gold DNA 227 
polymerase and optimised buffer components (Applied Biosystems).  House-keeping genes 228 
consisted of β-2-microglobulin (B2M), 18S rRNA, glyceraldehyde-3-phosphate 229 
dehydrogenase (GAPDH) and β-actin (ACTB).  The quantification of relative gene 230 
expressions was performed on an ABI Prism 7700 Sequence Detector (Applied Biosystems) 231 
under the cycling parameters: 95°C for 10 minutes, followed by 40 cycles of denaturation at 232 
95°C for 15 seconds and primer extension at 60°C for 1 minute. Data (Ct values) were 233 
analysed using the ABI Sequence Detector System software version 2.0 (Applied 234 
Biosystems) and the relative gene expression values, or fold changes, were calculated 235 
according to the manufacturer’s protocols. Briefly, values from the SGHEC-7 control (NC 236 
siRNA) and treated plates (TGIF-1-siRNA) were calculated as 2
-∆∆Ct
 (Livak and Schmittgen 237 
2001), and normalised to the average Ct value of the house-keeping genes. Target genes of 238 
TGIF-1 were identified by calculating the fold-change in gene expression levels for TGIF-1 239 
siRNA treated cells relative to the NC. Candidate genes that showed either a fold-change 240 
increase of >2 or a decrease of <2 in gene expression were identified. Data were analysed and 241 
compared with the NC transfected SGHEC-7 cells using Data Assist (Applied Biosystems). 242 
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Statistical Analysis 243 
Data are shown as mean ± SEM of n ≥ 3 independent experiments. Student’s t tests, 2 X 2 244 
contingency table with Fisher’s Exact Test and ANOVA with Bonferroni’s post-test were 245 
carried out using GraphPad Prism 5 (Graphpad Software Inc., La Jolla, CA, USA). A value of 246 
p<0.05 was considered to be statistically significant. 247 
248 
Page 11 of 32
12 
 
Results 249 
Clinical characteristics 250 
Table 1 describes the clinical characteristics of n=10 FGR and n=10 GMC patients, whose 251 
placentae were collected and used in the Australian arm of this study. As shown there were 252 
no significant differences in the gestational age, maternal age or infant sex between FGRs 253 
and controls. FGR cases showed significantly lower birth weights and lower placental 254 
weights. In addition, all FGR subjects had a birth weight below the 10th percentile for 255 
gestational age (Dobbins, et al. 2012) and either abnormal umbilical artery Doppler findings 256 
or oligohydramnios together with evidence of asymmetric growth (head circumference: 257 
abdominal circumference >95th centile). The Canadian FGR samples were associated with 258 
abnormal umbilical artery Doppler changes in all n=6 cases as previously described by Dunk 259 
et al. (Dunk, et al. 2012). 260 
 261 
Increased TGIF-1 expression in FGR placentae 262 
Real time-PCR was to used validate the initial microarray data which showed a trend towards 263 
increased expression in TGIF-1 mRNA. TGIF-1 mRNA expression was determined in two 264 
independent cohorts of FGR and control PLECs from Melbourne, Australia and Toronto, 265 
Canada. As shown in Figure 1, significant increases in TGIF-1 mRNA of 2.4 fold and 1.5 266 
fold were observed in PLECs isolated from FGR pregnancies compared with those from 267 
control pregnancies in the Australian (Figure 1A) and Canadian (Figure 1B) cohorts 268 
respectively. 269 
 270 
TGIF-1 is expressed in HUVEC and in the SGHEC-7 cell line  271 
Immunocytochemistry was used to demonstrate the expression and localisation of TGIF-1 272 
protein in HUVECs and SGHEC-7 cells, which were used as the in vitro cell culture model. 273 
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As apparent in Figure 2A (TGIF), TGIF-1 protein localised to the cell nuclei. Substitution of 274 
the primary antibody with mouse IgG2b control showed no such immunoreactivity (Figure 275 
2A, IgG control).  276 
 277 
TGIF-1 silencing in HUVEC and in the SGHEC-7 cell line 278 
Following transient siRNA transfection of HUVECS and SGHEC-7 cells for 72 hours, both 279 
TGIF-1 specific siRNAs (denoted as S1 and S2) significantly decreased TGIF-1 mRNA 280 
expression in comparison to the NC transfected cells (Figures 2B and 2C). This decrease in 281 
mRNA expression was further confirmed by examining the TGIF-1 protein expression in 282 
HUVECs SGHEC-7 cells post-transfection. As shown in Figure 2D, a decrease in 283 
immunoreactive TGIF-1 protein at 35kDa was evident in TGIF-1 siRNA treated cells 284 
compared with that of NC treated cells, with no change in GAPDH house-keeping protein 285 
loading control. Densitometric analysis confirmed a significant decrease in the protein 286 
expression of TGIF-1 in both S1 and S2 compared with NC treated cells (Figures 2E and 2F). 287 
 288 
TGIF-1 silencing decreases endothelial cell proliferation 289 
Following the siRNA inactivation of TGIF-1 in HUVECs and SGHEC-7cells, serum starved 290 
cells were assessed for their proliferative ability over 24 hours. As shown in Figures 3A and 291 
3B, TGIF-1 inactivation significantly decreased the proliferative potential of these cells 292 
compared with the NC.  293 
 294 
TGIF-1 silencing increases network formation 295 
The effect of TGIF-1 inactivation on the angiogenic potential of HUVECs and SGHEC-7 296 
cells was assessed by network formation assays. Angiogenic potential was determined by 297 
assessing branch points at the 4 hour time-point.  Significantly increased angiogenic potential 298 
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was observed in HUVECs and SGHEC-7 cells transfected with either S1 or S2 compared 299 
with NC transfected cells (Figures 3C, 3D and 3E). 300 
 301 
TGIF-1 silencing decreases SGHEC-7 invasive potential 302 
The matrix metalloproteinase activities of MMP-2 and MMP-9 in SGHEC-7 cells were 303 
determined by gelatin zymography and used as proxies for invasive potential. Activities of 304 
MMP-2 and -9 were assessed in the culture medium collected from TGIF-1 inactivated 305 
SGHEC-7 cells (S1 and S2) and compared with medium from NC transfected cells (Figures 306 
3F, 3G and 3H). TGIF-1 inactivation significantly decreased MMP-2 activity (Figure 3F) 307 
compared to the NC (p<0.05, ANOVA), but did not alter MMP-9 activity (Figure 3G). This 308 
was further confirmed in primary HUVEC following TGIF-1 inactivation using S1 siRNA 309 
compared to NC treated cells. MMP2 activity in S1 treated cells demonstrated a significant 310 
reduction (34%) in MMP2 activity (98.67 ± 1.7 (NC) vs. 33.67 ± 3.8 (S1), n=3, p<0.05) 311 
compared to NC, while there was no significant difference in MMP9 activity was observed 312 
following S1 treated cells compared to NC treated HUVEC cells (100.0 ± 2.5 (NC) vs. 87.67 313 
± 4.9 (S1), n=3, p=0.09). 314 
 315 
Downstream targets of TGIF-1 in endothelial cells 316 
The human angiogenesis array consisting of 92 human genes involved in the regulation of 317 
angiogenesis was utilised to identify potential downstream targets of TGIF-1. Following 318 
TGIF-1 inactivation with siRNA in SGHEC-7 cells, 51 genes were up-regulated, while 19 319 
genes were down-regulated. Changes in gene expression of four prioritised genes (ITGAV, 320 
NRP-1, ANGPT-1 and ANGPT-2) were then validated with real-time PCR in HUVECs and 321 
SGHEC-7 cells (Figure 4). ITGAV mRNA and NRP-1 mRNA were significantly increased in 322 
TGIF-1 siRNA transfected HUVECs (Figures 4A and 4C), with a similar trend observed in 323 
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the SGHEC-7 cells (Figures 4B and 4D). Expression of ANGPT-1 mRNA was significantly 324 
decreased in both TGIF-1 inactivated HUVECs (Figure 4E) and SGHEC-7 cells (Figure 4F). 325 
In contrast to ANGPT-1, ANGPT-2 mRNA was significantly increased in TGIF-1 inactivated 326 
HUVECs (Figure 4G), although no significant change was observed in that of SGHEC-7 cells 327 
(Figure 4H). 328 
329 
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Discussion 330 
Homeobox genes are important in the regulation of numerous vascular cell processes such as 331 
cell migration, invasion and proliferation (Douville and Wigle 2007). Previous studies in our 332 
laboratory reported a range of novel placental homeobox genes expressed in both 333 
microvascular and macrovascular ECs (Murthi, et al. 2008). One such example is homeobox 334 
gene TGIF-1, which is expressed at the mRNA level in both macrovascular ECs and 335 
microvascular ECs. Studies from our laboratory demonstrated a significant increase in TGIF-336 
1 in placentae from idiopathic FGR-affected pregnancies compared with uncomplicated 337 
control pregnancies. However, the functional role of TGIF-1 in human placentae, in 338 
particular its role in placental angiogenesis, is unclear. Therefore, the focus of this study was 339 
to investigate the functional role and the angiogenic downstream targets of TGIF-1. 340 
 341 
Nuclear expression of TGIF-1 protein in the primary HUVECs and the SGHEC-7 cell line, 342 
which were used as an in vitro EC model, was confirmed using immunocytochemistry. 343 
Successful knockdown of TGIF-1 expression at both the mRNA and protein levels was 344 
achieved using two independent TGIF-1 siRNAs to inactivate the TGIF-1 gene expression in 345 
ECs. Previous studies have demonstrated the angiogenic potential of the homeobox gene 346 
HEX in HUVECs (Nakagawa, et al. 2003).  This study found over-expression of HEX 347 
disrupted the ability of the ECs to migrate, proliferate and form tubular structures in response 348 
to VEGF stimulation. Apart from this study, limited information exists in the literature about 349 
the effects of modulating expression of homeobox genes on EC function in either HUVEC or 350 
in human placental microvascular ECs. Therefore, we investigated the functional role of 351 
TGIF-1 in placental angiogenesis and examined similar functions. 352 
 353 
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Microvascular ECs, which are found in the fetal capillaries of chorionic villi, exhibit a 354 
proliferative phenotype, as they play an important role in the vascularisation of the placenta 355 
(Thorin and Shreeve 1998). TGIF-1 inactivation in HUVECs and SGHEC-7 cells 356 
significantly reduced their proliferative ability, while increasing the angiogenic potential of 357 
the ECs. This demonstrates that TGIF-1 plays a role in regulating the ability of ECs to form 358 
cell-cell and cell-matrix connections. The effect of TGIF-1 in vascular development is not 359 
surprising as mouse studies have found embryos lacking Tgif-1 to be extremely growth 360 
restricted with placental defects affecting the vasculature (Bartholin, et al. 2008). The 361 
overexpression of TGIF-1 in human FGR placental endothelium suggests that there may be 362 
excessive proliferation with insufficient differentiation, resulting in impaired placental 363 
angiogenesis.  364 
 365 
Another critical aspect of placental angiogenesis is the degradation of the basement 366 
membrane by proteases released by ECs (Kaufmann, et al. 2004). Metalloproteinases 367 
(MMPs) are proteases that belong to a family of at least 15 secreted and membrane-bound 368 
zinc-endopeptidases. The results of the current study indicate a significant difference in 369 
MMP-2 activity in HUVECs and SGHEC-7 cells transfected with TGIF-1 siRNA compared 370 
with NC transfected ECs.  Other studies have found MMP-1, -2, -3, -9 and TIMP1 enzymatic 371 
activity to be associated with ECs (Hanemaaijer, et al. 1993). However, under basal 372 
conditions without growth supplementation, MMP1 and MMP2 activity is evident but MMP9 373 
is not, suggesting this is not constitutively secreted (Jackson and Nguyen 1997). Therefore, it 374 
is possible due to the use of serum-free medium in our experiments, there was no observable 375 
effect on MMP9 activity. Dysfunctional secretion of these enzymes would significantly 376 
impact basement membrane degradation and invasive potential, which would affect the 377 
vasculature development. 378 
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To determine TGIF-1’s role as a functional regulator of angiogenesis, we investigated 379 
downstream targets of TGIF-1 in EC angiogenesis by utilising low density angiogenesis-380 
related PCR arrays to profile alterations in gene expression. The array consists of 92 381 
angiogenesis related genes targeting known angiogenic growth factors including VEGF, 382 
endostatin and cell adhesion molecules. In addition, the array contains markers and targets for 383 
angiogenesis and lymphangiogenesis. From the array, four candidate genes that showed 384 
altered expression following TGIF-1 inactivation were selected for further validation on 385 
independent cultures of TGIF-1 inactivated HUVECs and SGHEC-7 cells. NRP-1 and ITGAV 386 
showed increases in gene expression consistent with the array. ANGPT-1 mRNA expression 387 
was significantly decreased in HUVECs and SGHEC-7 cells, while the related ANGPT-2 388 
showed an opposite increase in mRNA expression.  389 
 390 
The TGIF-1 downstream target gene NRP-1 is an important regulator of angiogenesis 391 
particularly in the cardiovascular system (Kawakami, et al. 2002). NRP-1 acts as a co-392 
receptor for VEGF, which is a principal promoter of angiogenic processes and is involved in 393 
the differentiation, tube formation and vascular maturation of ECs (Flamme, et al. 1997). 394 
From the low density array, VEGF was also up-regulated as a result of TGIF-1 silencing. 395 
Thus, it is speculated that NRP-1, in cooperation with VEGF, may help regulate the 396 
formation of EC networks. Consequently, with overexpression of TGIF-1 in FGR placentae, 397 
the downstream NRP-1 targeted gene would be expected to be decreased. A recent study 398 
confirms this, demonstrating significantly reduced NRP-1 expression in placentae from 399 
human FGR-affected pregnancies with an absent end-diastolic flow in the umbilical artery 400 
(Maulik, et al. 2015). Hence, TGIF-1 may be an important upstream regulator of placental 401 
angiogenesis.  402 
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Our study also identifies ITGAV as a downstream angiogenic target of TGIF-1. ITGAV codes 403 
for the αV integrin and is involved in cell adhesion. Overexpression of TGIF-1 will lead to a 404 
reduction in ITGAV expression. Deletion of Itgav in mice shows impaired vascular 405 
development in the central nervous and the ophthalmic systems, similar to that seen in the 406 
deletion of Nrp-1 (Arnold, et al. 2012). A major function of this integrin is to activate TGFβ1 407 
signalling (Arnold, et al. 2012), which is a crucial signalling pathway in placental 408 
development. Therefore, impaired placental vascularisation in human FGR may be a result of 409 
TGIF-1 overexpression reducing ITGAV expression. 410 
 411 
The TGIF-1 downstream targets of ANGPT1 and ANGPT2 code for angiopoietins 1 and 2 412 
respectively, and are critical mediators of vascular development. Angiopoietin 2 (ANGPT2) 413 
is an antagonist for both angiopoietin 1 (ANGPT1) and the TIE-2 receptor (Drenkhahn, et al. 414 
2004). ANGPT1 is known to provide a stabilising signal through the TIE-2 receptor, which 415 
can be blocked by ANGPT2 to prevent vascular sprouting only if VEGF is absent 416 
(Maisonpierre, et al. 1997). Increased placental expression of TGIF-1 observed in human 417 
FGR is expected to upregulate ANGPT1 and downregulate ANGPT2 mRNA. Altered 418 
expression of both ANGPT1 and ANGPT2 is implicated in an ovine model of FGR (Hagen, et 419 
al. 2005). Imbalances in the concentrations of angiopoietins 1 and 2 may contribute to the 420 
villous pathology of the FGR microvasculature via the induction of premature maturation of 421 
the terminal villi capillaries (Dunk, et al. 2000). Thus, angiopoietin signalling may be another 422 
pathway through which pathological TGIF-1 overexpression impacts placental angiogenesis 423 
in human FGR. 424 
 425 
In conclusion, this is the first study to report an increased expression of TGIF-1 in PLECs 426 
from FGR-affected pregnancies. In vitro functional analyses suggest TGIF-1 regulates 427 
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placental angiogenesis through effects on the ability of ECs to proliferate, form networks and 428 
invade. Increased expression of TGIF-1 in endothelial cells may contribute to reduced 429 
branching angiogenesis observed in FGR placentae. Our study also identified ITGAV, NRP-1, 430 
ANGPT1 and ANGPT2 as downstream targets of TGIF-1, which are important mediators of 431 
placental angiogenesis in FGR. Thus, the increased expression of homeobox gene TGIF-1 432 
may be involved in the molecular mechanisms underlying the aberrant angiogenesis observed 433 
in human FGR.  434 
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Figure legends 1 
Figure 1 2 
Increased TGIF-1 mRNA expression relative to housekeeping genes in endothelial cells from 3 
FGR compared with control placentae was determined by real-time PCR analysis in two 4 
independent cohorts from Melbourne, Australia (A) and Toronto, Canada (B). *p<0.05, 5 
***p<0.001, Student’s t test. 6 
 7 
Figure 2 8 
TGIF-1 expression in the primary HUVECs and the SGHEC-7 cell line. Immunoreactive 9 
TGIF-1 localised to the nuclei in HUVECs and SGHEC-7 cells as denoted by black arrows, 10 
which is absent in the negative IgG control (A). Scale bar represents 100 µm. siRNA 11 
inactivation with resulted in reduced TGIF-1 mRNA expression in HUVECs (B) and 12 
SGHEC-7 cells (C), which was validated using western immunoblotting (D) and confirmed at 13 
the protein level (E & F). NC denotes the non-specific siRNA used as the negative control, 14 
while S1 and S2 refer to the two independent TGIF-specific siRNAs used in the siRNA 15 
transfection experiments. ***p<0.001, One Way ANOVA with Bonferroni’s post test. 16 
 17 
Figure 3 18 
Functional analyses of TGIF-1 in HUVECs and SGHEC-7 cells. TGIF-1 siRNA inactivation 19 
significantly reduced proliferation (A & B), increased tube formation (C, D & E) and 20 
decreased MMP-2 activity (F), with no effect on MMP-9 activity (G) of ECs. Representative 21 
experiments of the tube formation assay and zymography are presented in E and H 22 
respectively. NC denotes the non-specific siRNA used as the negative control, while S1 and 23 
S2 refer to the two independent TGIF-specific siRNAs used in the siRNA transfection 24 
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experiments. *p<0.05, **p<0.01, ***p<0.001, One Way ANOVA with Bonferroni’s post-25 
test. 26 
 27 
Figure 4 28 
Validation of angiogenesis gene screen following TGIF-1 siRNA inactivation in HUVECs 29 
and the SGHEC-7 cell line. Altered mRNA expression of ITGAV (A & B), NRP-1 (C & D), 30 
ANGPT-1 (E & F) and ANGPT-2 (G & H) were verified using real-time PCR after 31 
normalising to the 18S rRNA housekeeping gene. NC denotes the non-specific siRNA used as 32 
the negative control, while S1 and S2 refer to the two independent TGIF-specific siRNAs 33 
used in the siRNA transfection experiments. *p<0.05, **p<0.01, ***p<0.001, Student’s t test. 34 
 35 
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Figure 1: TGIF-1 expression in FGR and control  
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Figure 2. TGIF-1 expression in HUVEC and SGHEC-7 cells.  
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Figure 3: Functional role of TGIF-1 in endothelial cells  
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Figure 4: Downstream targets of TGIF-1 in endothelial cells  
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Tables 1 
Table 1 2 
Clinical characteristics of Australian samples 3 
Characteristics
a
 GMC (n=10) FGR (n=10) P-value
b
 
Maternal Age (years) 34.8±1.6 32.7±2.0 0.41 
Gestation at Delivery (weeks) 38.7±0.3 38.4±0.4 0.52 
Infant Weight (g) 3406.3±122.8 2448.7±63.3 <0.0001 
Placental Weight (g) 662.4±32.8 471.3±28.8 <0.001 
Parity 5 primi, 5 multi 4 primi, 6 multi 1.00 
Infant Sex 6F, 4M 9F, 1M 0.30 
a
 Shown is the mean ± SEM with ranges shown in brackets unless stated otherwise. 4 
b 
Student’s t test for parametric data and 2 X 2 contingency table with Fisher’s Exact Test for 5 
categorical data were used where appropriate. 6 
 7 
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